Many flaviviruses such as Dengue virus, West Nile virus, and Yellow Fever virus cause significant human diseases. However, no clinically approved antiviral therapy is available for treatment of flavivirus infections. Therefore, the development of vaccines and antiviral agents for prevention and treatment of flavivirus infections is a clear public health priority. Previously, we found a general mechanism that the flavivirus NS5 sequentially methylates the guanine N7 on the cap and ribose 2'-OH on the first transcribed nucleotide. We also found that the N7 methyltransferase (MTase) is essential for flavivirus replication, since defects in N7 MTase activity lead to defects in viral replication. We also identified a flavivirus-conserved pocket near the methyl- donor SAM-binding pocket. In addition, we identified a lead MTase inhibitor, and found that inhibitors against the N7 activity of the WNV MTase can inhibit viral growth. These results clearly demonstrate that flavivirus MTase is a novel target for development of antiviral therapy. The goal of this application is to study the molecular inhibition of the essential flavivirus MTase. We will accomplish the overall objective of this application by pursuing three specific aims.
Aim 1. Characterization of the flavivirus methyltransferase. We will further characterize the flavivirus- conserved pocket near the co-factor SAM-binding site using mutagenesis and reverse genetic approaches.
Aim 2. Structure-based design and development of MTase inhibitors. We will perform structure-based design and synthesis of specific inhibitors against flavivirus MTases.
Aim 3. Performance of in-depth structure-activity studies and determination of X-ray structures of selected inhibitors to gain molecular insight. We will evaluate the inhibition ability of synthesized MTase inhibitors using in vitro MTase assay, cell-based replicon inhibition assay, and viral reduction assay. Advanced compounds will be further characterized by in vivo animal studies, in-depth drug resistance studies, and co-crystal structure determination of the MTase-inhibitor complexes. The proposed research is innovative and significant. The knowledge acquired from this study will significantly advance our understanding of flavivirus cap methylation and lead to the development of inhibitors of the flavivirus MTase for antiviral therapy.

Public Health Relevance

Many flaviviruses cause significant human diseases. No effective antiviral therapy is currently available for treatment of flavivirus infections. The current proposal is to define the molecular mechanism and function of the flavivirus MTase, and to develop potent MTase inhibitors to treat flavivirus-associated diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI094335-03
Application #
8434274
Study Section
Drug Discovery and Mechanisms of Antimicrobial Resistance Study Section (DDR)
Program Officer
Tseng, Christopher K
Project Start
2011-03-01
Project End
2016-02-28
Budget Start
2013-03-01
Budget End
2014-02-28
Support Year
3
Fiscal Year
2013
Total Cost
$597,502
Indirect Cost
$117,592
Name
Wadsworth Center
Department
Type
DUNS #
153695478
City
Menands
State
NY
Country
United States
Zip Code
12204
Ghosh, Arun K; Kassekert, Luke A; Bungard, Joseph D (2016) Enantioselective total synthesis and structural assignment of callyspongiolide. Org Biomol Chem 14:11357-11370
Brecher, Matthew B; Li, Zhong; Zhang, Jing et al. (2015) Refolding of a fully functional flavivirus methyltransferase revealed that S-adenosyl methionine but not S-adenosyl homocysteine is copurified with flavivirus methyltransferase. Protein Sci 24:117-28
Vernekar, Sanjeev Kumar V; Qiu, Li; Zhang, Jing et al. (2015) 5'-Silylated 3'-1,2,3-triazolyl Thymidine Analogues as Inhibitors of West Nile Virus and Dengue Virus. J Med Chem 58:4016-28
Brecher, Matthew; Chen, Hui; Li, Zhong et al. (2015) Identification and Characterization of Novel Broad-Spectrum Inhibitors of the Flavivirus Methyltransferase. ACS Infect Dis 1:340-9
Brecher, Matthew; Chen, Hui; Liu, Binbin et al. (2015) Novel Broad Spectrum Inhibitors Targeting the Flavivirus Methyltransferase. PLoS One 10:e0130062
Ghosh, Arun K; Lv, Kai (2014) A convergent synthesis of carbocyclic sinefungin and its C5 epimer. European J Org Chem 2014:6761-6768
Gamari, Benjamin D; Zhang, Dianwen; Buckman, Richard E et al. (2014) Inexpensive electronics and software for photon statistics and correlation spectroscopy. Am J Phys 82:708-722
Chen, Hui; Zhou, Bing; Brecher, Matthew et al. (2013) S-adenosyl-homocysteine is a weakly bound inhibitor for a flaviviral methyltransferase. PLoS One 8:e76900
Brecher, Matthew; Zhang, Jing; Li, Hongmin (2013) The flavivirus protease as a target for drug discovery. Virol Sin 28:326-36
Chen, Hui; Liu, Lihui; Jones, Susan A et al. (2013) Selective inhibition of the West Nile virus methyltransferase by nucleoside analogs. Antiviral Res 97:232-9

Showing the most recent 10 out of 11 publications